Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Exact Sciences Corp has a consensus price target of $72.28 based on the ratings of 28 analysts. The high is $90 issued by Bernstein on October 30, 2024. The low is $54 issued by RBC Capital on May 2, 2025. The 3 most-recent analyst ratings were released by Barclays, RBC Capital, and Evercore ISI Group on May 2, 2025, respectively. With an average price target of $65 between Barclays, RBC Capital, and Evercore ISI Group, there's an implied 12.30% upside for Exact Sciences Corp from these most-recent analyst ratings.
1calculated from analyst ratings
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/02/2025 | Buy Now | 29.58% | Barclays | Luke Sergott50% | $55 → $75 | Maintains | Overweight | Get Alert |
05/02/2025 | Buy Now | -6.7% | RBC Capital | Gerard Cassidy72% | $52 → $54 | Maintains | Sector Perform | Get Alert |
05/02/2025 | Buy Now | 14.03% | Evercore ISI Group | Vijay Kumar51% | $60 → $66 | Maintains | Outperform | Get Alert |
05/02/2025 | Buy Now | 24.4% | Baird | Catherine Schulte66% | $69 → $72 | Maintains | Outperform | Get Alert |
04/11/2025 | Buy Now | 3.66% | Guggenheim | Subbu Nambi41% | $60 → $60 | Reiterates | Buy → Buy | Get Alert |
04/10/2025 | Buy Now | -4.98% | Barclays | Luke Sergott50% | $65 → $55 | Maintains | Overweight | Get Alert |
04/10/2025 | Buy Now | 3.66% | Mizuho | Anthony Petrone63% | → $60 | Initiates | → Outperform | Get Alert |
03/13/2025 | Buy Now | -10.16% | RBC Capital | Gerard Cassidy72% | → $52 | Initiates | → Sector Perform | Get Alert |
02/26/2025 | Buy Now | 20.94% | Piper Sandler | David Westenberg58% | $75 → $70 | Maintains | Overweight | Get Alert |
02/24/2025 | Buy Now | 26.12% | Scotiabank | Sung Ji Nam44% | $70 → $73 | Maintains | Sector Outperform | Get Alert |
02/20/2025 | Buy Now | 12.3% | B of A Securities | Derik De Bruin84% | $72 → $65 | Maintains | Buy | Get Alert |
02/20/2025 | Buy Now | 12.3% | Barclays | Luke Sergott50% | $70 → $65 | Maintains | Overweight | Get Alert |
01/23/2025 | Buy Now | 20.94% | Barclays | Luke Sergott50% | → $70 | Initiates | → Overweight | Get Alert |
01/13/2025 | Buy Now | 12.3% | Benchmark | Bruce Jackson40% | $65 → $65 | Reiterates | Buy → Buy | Get Alert |
12/13/2024 | Buy Now | 24.4% | B of A Securities | Derik De Bruin84% | $75 → $72 | Maintains | Buy | Get Alert |
11/26/2024 | Buy Now | 48.58% | TD Cowen | Dan Brennan62% | $82 → $86 | Maintains | Buy | Get Alert |
11/26/2024 | Buy Now | 29.58% | BTIG | Mark Massaro72% | $65 → $75 | Maintains | Buy | Get Alert |
11/11/2024 | Buy Now | 29.58% | Piper Sandler | David Westenberg58% | $85 → $75 | Maintains | Overweight | Get Alert |
11/06/2024 | Buy Now | 29.58% | Citigroup | Patrick Donnelly80% | $80 → $75 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 46.86% | Jefferies | Brandon Couillard23% | $84 → $85 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 12.3% | BTIG | Mark Massaro72% | $82 → $65 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 15.76% | Stifel | Daniel Arias78% | $82 → $67 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 29.58% | Canaccord Genuity | Kyle Mikson36% | $95 → $75 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 41.67% | TD Cowen | Dan Brennan62% | $90 → $82 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 12.3% | Goldman Sachs | Matthew Sykes63% | $75 → $65 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 3.66% | Evercore ISI Group | Vijay Kumar51% | $80 → $60 | Maintains | Outperform | Get Alert |
11/06/2024 | Buy Now | 12.3% | Craig-Hallum | Alex Nowark65% | $82 → $65 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 12.3% | Benchmark | Bruce Jackson40% | $67 → $65 | Maintains | Buy | Get Alert |
11/06/2024 | Buy Now | 15.76% | Baird | Catherine Schulte66% | $70 → $67 | Maintains | Outperform | Get Alert |
10/30/2024 | Buy Now | 55.49% | Bernstein | Eve Burstein45% | $75 → $90 | Maintains | Outperform | Get Alert |
10/29/2024 | Buy Now | 64.13% | Canaccord Genuity | Kyle Mikson36% | $75 → $95 | Maintains | Buy | Get Alert |
10/01/2024 | Buy Now | 38.22% | Evercore ISI Group | Vijay Kumar51% | $72 → $80 | Maintains | Outperform | Get Alert |
09/26/2024 | Buy Now | — | Raymond James | Andrew Cooper53% | — | Reiterates | → Market Perform | Get Alert |
09/13/2024 | Buy Now | 29.58% | Canaccord Genuity | Kyle Mikson36% | $75 → $75 | Maintains | Buy | Get Alert |
09/12/2024 | Buy Now | 46.86% | Piper Sandler | David Westenberg58% | $75 → $85 | Maintains | Overweight | Get Alert |
08/27/2024 | Buy Now | 29.58% | Wells Fargo | Brandon Couillard23% | → $75 | Initiates | → Overweight | Get Alert |
08/01/2024 | Buy Now | 15.76% | Benchmark | Bruce Jackson40% | $91 → $67 | Maintains | Buy | Get Alert |
08/01/2024 | Buy Now | 41.67% | Stifel | Daniel Arias78% | $100 → $82 | Maintains | Buy | Get Alert |
07/17/2024 | Buy Now | 29.58% | Goldman Sachs | Matthew Sykes63% | $88 → $75 | Maintains | Buy | Get Alert |
07/02/2024 | Buy Now | 24.4% | Evercore ISI Group | Vijay Kumar51% | $80 → $72 | Maintains | Outperform | Get Alert |
06/27/2024 | Buy Now | 20.94% | BTIG | Mark Massaro72% | $80 → $70 | Maintains | Buy | Get Alert |
06/27/2024 | Buy Now | 20.94% | Scotiabank | Sung Ji Nam44% | → $70 | Initiates | → Sector Outperform | Get Alert |
06/26/2024 | Buy Now | 20.94% | BTIG | Mark Massaro72% | $80 → $70 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | 38.22% | BTIG | Mark Massaro72% | $85 → $80 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | 46.86% | Canaccord Genuity | Kyle Mikson36% | $90 → $85 | Maintains | Buy | Get Alert |
05/09/2024 | Buy Now | 38.22% | Citigroup | Patrick Donnelly80% | $100 → $80 | Maintains | Buy | Get Alert |
04/03/2024 | Buy Now | 72.77% | Citigroup | Patrick Donnelly80% | → $100 | Maintains | Buy | Get Alert |
02/22/2024 | Buy Now | 55.49% | Canaccord Genuity | Kyle Mikson36% | $100 → $90 | Maintains | Buy | Get Alert |
01/02/2024 | Buy Now | 57.22% | Benchmark | Bruce Jackson40% | → $91 | Upgrade | Hold → Buy | Get Alert |
12/14/2023 | Buy Now | 55.49% | Guggenheim | Subbu Nambi41% | → $90 | Initiates | → Buy | Get Alert |
12/13/2023 | Buy Now | — | Wolfe Research | Doug Schenkel71% | — | Initiates | → Outperform | Get Alert |
11/03/2023 | Buy Now | 55.49% | Goldman Sachs | Matthew Sykes63% | $100 → $90 | Maintains | Buy | Get Alert |
10/16/2023 | Buy Now | 38.22% | Piper Sandler | David Westenberg58% | $90 → $80 | Maintains | Overweight | Get Alert |
10/10/2023 | Buy Now | 55.49% | Piper Sandler | David Westenberg58% | → $90 | Upgrade | Neutral → Overweight | Get Alert |
09/28/2023 | Buy Now | 43.4% | Bernstein | Eve Burstein45% | → $83 | Initiates | → Outperform | Get Alert |
08/08/2023 | Buy Now | 55.49% | Piper Sandler | David Westenberg58% | $80 → $90 | Maintains | Neutral | Get Alert |
08/03/2023 | Buy Now | 90.05% | Jefferies | Brandon Couillard23% | $100 → $110 | Maintains | Buy | Get Alert |
08/02/2023 | Buy Now | 55.49% | Credit Suisse | Dan Leonard54% | $75 → $90 | Maintains | Neutral | Get Alert |
08/02/2023 | Buy Now | 109.05% | Baird | Catherine Schulte66% | $99 → $121 | Maintains | Outperform | Get Alert |
08/02/2023 | Buy Now | — | Benchmark | Bruce Jackson40% | — | Downgrade | Buy → Hold | Get Alert |
07/24/2023 | Buy Now | 90.05% | Goldman Sachs | Matthew Sykes63% | $85 → $110 | Maintains | Buy | Get Alert |
07/21/2023 | Buy Now | 90.05% | Goldman Sachs | Matthew Sykes63% | $85 → $110 | Maintains | Buy | Get Alert |
06/23/2023 | Buy Now | 98.69% | Canaccord Genuity | Kyle Mikson36% | $92 → $115 | Maintains | Buy | Get Alert |
06/22/2023 | Buy Now | 124.6% | Citigroup | Patrick Donnelly80% | $100 → $130 | Maintains | Buy | Get Alert |
06/22/2023 | Buy Now | 65.86% | Benchmark | Bruce Jackson40% | → $96 | Reiterates | Buy → Buy | Get Alert |
06/21/2023 | Buy Now | 46.86% | Stifel | Daniel Arias78% | → $85 | Reiterates | Buy → Buy | Get Alert |
06/21/2023 | Buy Now | 58.95% | Canaccord Genuity | Kyle Mikson36% | → $92 | Reiterates | Buy → Buy | Get Alert |
06/07/2023 | Buy Now | 72.77% | Jefferies | Brandon Couillard23% | $82 → $100 | Maintains | Buy | Get Alert |
05/11/2023 | Buy Now | 72.77% | Citigroup | Patrick Donnelly80% | $90 → $100 | Maintains | Buy | Get Alert |
05/10/2023 | Buy Now | 41.67% | Jefferies | Brandon Couillard23% | $72 → $82 | Maintains | Buy | Get Alert |
05/10/2023 | Buy Now | 52.04% | B of A Securities | Derik De Bruin84% | $80 → $88 | Maintains | Buy | Get Alert |
05/10/2023 | Buy Now | 29.58% | Credit Suisse | Dan Leonard54% | $70 → $75 | Maintains | Neutral | Get Alert |
05/10/2023 | Buy Now | 71.04% | Baird | Catherine Schulte66% | $92 → $99 | Maintains | Outperform | Get Alert |
05/10/2023 | Buy Now | 46.86% | Craig-Hallum | Alex Nowark65% | $55 → $85 | Upgrade | Hold → Buy | Get Alert |
05/05/2023 | Buy Now | 26.12% | UBS | Elizabeth Garcia70% | → $73 | Initiates | → Neutral | Get Alert |
03/15/2023 | Buy Now | 34.76% | Benchmark | Bruce Jackson40% | $54 → $78 | Maintains | Buy | Get Alert |
03/09/2023 | Buy Now | 55.49% | Citigroup | Patrick Donnelly80% | $70 → $90 | Upgrade | Neutral → Buy | Get Alert |
03/03/2023 | Buy Now | 20.94% | Piper Sandler | David Westenberg58% | $50 → $70 | Maintains | Neutral | Get Alert |
02/22/2023 | Buy Now | 31.31% | Cowen & Co. | Dan Brennan62% | $56 → $76 | Maintains | Outperform | Get Alert |
02/22/2023 | Buy Now | 58.95% | Baird | Catherine Schulte66% | $89 → $92 | Maintains | Outperform | Get Alert |
02/22/2023 | Buy Now | 38.22% | BTIG | Mark Massaro72% | $85 → $80 | Maintains | Buy | Get Alert |
02/22/2023 | Buy Now | 29.58% | Canaccord Genuity | Kyle Mikson36% | $70 → $75 | Maintains | Buy | Get Alert |
02/22/2023 | Buy Now | 20.94% | Citigroup | Patrick Donnelly80% | $35 → $70 | Maintains | Neutral | Get Alert |
02/22/2023 | Buy Now | 20.94% | Credit Suisse | Dan Leonard54% | → $70 | Reiterates | → Neutral | Get Alert |
02/10/2023 | Buy Now | 20.94% | Credit Suisse | Dan Leonard54% | $50 → $70 | Downgrade | Outperform → Neutral | Get Alert |
01/18/2023 | Buy Now | — | Raymond James | Andrew Cooper53% | — | Downgrade | Outperform → Market Perform | Get Alert |
01/12/2023 | Buy Now | 29.58% | SVB Leerink | Puneet Souda57% | $70 → $75 | Maintains | Outperform | Get Alert |
01/06/2023 | Buy Now | 20.94% | SVB Leerink | Puneet Souda57% | $60 → $70 | Maintains | Outperform | Get Alert |
12/16/2022 | Buy Now | 20.94% | Jefferies | Brandon Couillard23% | → $70 | Maintains | Buy | Get Alert |
11/14/2022 | Buy Now | -13.61% | Piper Sandler | David Westenberg58% | $40 → $50 | Maintains | Neutral | Get Alert |
11/08/2022 | Buy Now | 3.66% | Raymond James | Andrew Cooper53% | $70 → $60 | Maintains | Outperform | Get Alert |
11/07/2022 | Buy Now | 12.3% | BTIG | Mark Massaro72% | $70 → $65 | Maintains | Buy | Get Alert |
10/19/2022 | Buy Now | — | Craig-Hallum | Alexander Nowak53% | — | Downgrade | Buy → Hold | Get Alert |
08/25/2022 | Buy Now | -4.98% | Credit Suisse | Dan Leonard54% | → $55 | Initiates | → Outperform | Get Alert |
08/17/2022 | Buy Now | -30.89% | Piper Sandler | David Westenberg58% | $50 → $40 | Maintains | Overweight | Get Alert |
08/03/2022 | Buy Now | 3.66% | Craig-Hallum | Alex Nowark65% | $81 → $60 | Maintains | Buy | Get Alert |
08/03/2022 | Buy Now | 15.76% | Cowen & Co. | Dan Brennan62% | $83 → $67 | Maintains | Outperform | Get Alert |
08/03/2022 | Buy Now | 20.94% | BTIG | Mark Massaro72% | $100 → $70 | Maintains | Buy | Get Alert |
08/03/2022 | Buy Now | 29.58% | Baird | Catherine Ramsey49% | $90 → $75 | Maintains | Outperform | Get Alert |
08/03/2022 | Buy Now | -13.61% | Citigroup | Patrick Donnelly80% | $65 → $50 | Maintains | Neutral | Get Alert |
The latest price target for Exact Sciences (NASDAQ:EXAS) was reported by Barclays on May 2, 2025. The analyst firm set a price target for $75.00 expecting EXAS to rise to within 12 months (a possible 29.58% upside). 43 analyst firms have reported ratings in the last year.
The latest analyst rating for Exact Sciences (NASDAQ:EXAS) was provided by Barclays, and Exact Sciences maintained their overweight rating.
The last upgrade for Exact Sciences Corp happened on January 2, 2024 when Benchmark raised their price target to $91. Benchmark previously had a hold for Exact Sciences Corp.
The last downgrade for Exact Sciences Corp happened on August 2, 2023 when Benchmark changed their price target from N/A to N/A for Exact Sciences Corp.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Exact Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Exact Sciences was filed on May 2, 2025 so you should expect the next rating to be made available sometime around May 2, 2026.
While ratings are subjective and will change, the latest Exact Sciences (EXAS) rating was a maintained with a price target of $55.00 to $75.00. The current price Exact Sciences (EXAS) is trading at is $57.88, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.